Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dispenzieri

Showing results (31-40 of 154) with videos related to

Pageof 16
Sort By:
Blood|March 27, 2001
Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasiaA Tefferi, M A Elliot, S Y Yoon, et al.
The American Journal of Cardiology|October 9, 2001
Troponin levels in patients with amyloid cardiomyopathy undergoing cardiac transplantationW L Miller, R S Wright, C G McGregor, et al.
Leukemia|August 21, 2012
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaG Bianchi, R A Kyle, D R Larson, et al.
Leukemia|May 14, 2011
Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AXD K Walters, X Wu, R C Tschumper, et al.
Leukemia|March 31, 2012
Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferationB K Arendt, D K Walters, X Wu, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
Trend toward improved day 100 and two-year survival following stem cell transplantation for AL: a comparison before and after 2006M A Gertz, M Q Lacy, A Dispenzieri, et al.
Blood Cancer Journal|September 10, 2013
Pomalidomide: the new immunomodulatory agent for the treatment of multiple myelomaA A Chanan-Khan, A Swaika, A Paulus, et al.
Leukemia|October 24, 2013
Long-term response to lenalidomide in patients with newly diagnosed multiple myelomaT V Kourelis, S K Kumar, G Srivastava, et al.
Blood Cancer Journal|June 25, 2021
Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patientsA Visram, C Soof, S V Rajkumar, et al.
Bone Marrow Transplantation|September 12, 2012
Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosisM A Gertz, M Q Lacy, A Dispenzieri, et al.
Pageof 16

Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
Blood|March 27, 2001
Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasiaA Tefferi, M A Elliot, S Y Yoon, et al.
The American Journal of Cardiology|October 9, 2001
Troponin levels in patients with amyloid cardiomyopathy undergoing cardiac transplantationW L Miller, R S Wright, C G McGregor, et al.
Leukemia|August 21, 2012
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaG Bianchi, R A Kyle, D R Larson, et al.
Leukemia|May 14, 2011
Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AXD K Walters, X Wu, R C Tschumper, et al.
Leukemia|March 31, 2012
Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferationB K Arendt, D K Walters, X Wu, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
Trend toward improved day 100 and two-year survival following stem cell transplantation for AL: a comparison before and after 2006M A Gertz, M Q Lacy, A Dispenzieri, et al.
Blood Cancer Journal|September 10, 2013
Pomalidomide: the new immunomodulatory agent for the treatment of multiple myelomaA A Chanan-Khan, A Swaika, A Paulus, et al.
Leukemia|October 24, 2013
Long-term response to lenalidomide in patients with newly diagnosed multiple myelomaT V Kourelis, S K Kumar, G Srivastava, et al.
Blood Cancer Journal|June 25, 2021
Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patientsA Visram, C Soof, S V Rajkumar, et al.
Bone Marrow Transplantation|September 12, 2012
Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosisM A Gertz, M Q Lacy, A Dispenzieri, et al.
Pageof 16